Citizens cuts Kalvista Pharmaceuticals stock price target on steady launch

📌 Key Takeaways

• Citizens lowered Kalvista Pharmaceuticals' stock price target.
• The adjustment follows the company's steady product launch.
• The launch performance met expectations but prompted a revised valuation.
• The move reflects a reassessment of near-term growth potential.

🏷️ Themes

Financial Analysis, Pharmaceuticals

Entity Intersection Graph

No entity connections available yet for this article.

Source

investing.com